Lollert André, Stihl Clemens, Hötker Andreas M, Mengel Eugen, König Jochem, Laudemann Katharina, Gökce Seyfullah, Düber Christoph, Staatz Gundula
Department of Diagnostic and Interventional Radiology, Section of Pediatric Radiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Department of Diagnostic and Interventional Radiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany.
PLoS One. 2018 Jan 9;13(1):e0190784. doi: 10.1371/journal.pone.0190784. eCollection 2018.
The objective of this study was to evaluate a quantitative method based on conventional T1-weighted magnetic resonance (MR) imaging to assess fatty muscular degeneration in patients with late-onset Pompe disease and to compare it with semi-quantitative visual evaluation (the Mercuri score). In addition, a long-term retrospective data analysis was performed to evaluate treatment response to enzyme replacement therapy with alglucosidase alfa.
MR images of the lumbar spine were acquired in 41 patients diagnosed with late-onset Pompe disease from 2006 through 2015. Two independent readers retrospectively evaluated fatty degeneration of the psoas and paraspinal muscles by applying the Mercuri score. Quantitative semi-automated muscle and fat tissue separation was performed, and inter-observer agreement and correlations with clinical parameters were assessed. Follow-up examinations were performed in 13 patients treated with alglucosidase alfa after a median of 39 months; in 7/13 patients, an additional follow-up examination was completed after a median of 63 months.
Inter-observer agreement was high. Measurements derived from the quantitative method correlated well with Medical Research Council scores of muscle strength, with moderate correlations found for the 6-minute walk test, the 4-step stair climb test, and spirometry in the supine position. A significant increase in the MR-derived fat fraction of the psoas muscle was found between baseline and follow-up 1 (P = 0.016), as was a significant decrease in the performance on the 6-minute walk test (P = 0.006) and 4-step stair climb test (P = 0.034), as well as plasma creatine kinase (P = 0.016). No statistically significant difference in clinical or MR-derived parameters was found between follow-up 1 and follow-up 2.
Quantification of fatty muscle degeneration using the semi-automated method can provide a more detailed overview of disease progression than semi-quantitative Mercuri scoring. MR-derived data correlated with clinical symptoms and patient exercise capacity. After an initial worsening, the fat fraction of the psoas muscle and performance on the 6-minute walk test stayed constant during long-term follow-up under enzyme replacement therapy.
本研究的目的是评估一种基于传统T1加权磁共振成像的定量方法,以评估晚发型庞贝病患者的脂肪性肌肉变性,并将其与半定量视觉评估(Mercuri评分)进行比较。此外,进行了一项长期回顾性数据分析,以评估用阿糖苷酶α进行酶替代治疗的反应。
对2006年至2015年期间诊断为晚发型庞贝病的41例患者进行腰椎磁共振成像。两名独立的阅片者通过应用Mercuri评分对腰大肌和椎旁肌的脂肪变性进行回顾性评估。进行了定量半自动肌肉和脂肪组织分离,并评估了观察者间的一致性以及与临床参数的相关性。对13例接受阿糖苷酶α治疗的患者进行了随访检查,中位随访时间为39个月;在7/13例患者中,中位随访63个月后完成了额外的随访检查。
观察者间的一致性较高。定量方法得出的测量值与医学研究委员会的肌肉力量评分相关性良好,在6分钟步行试验、4级楼梯攀爬试验和仰卧位肺活量测定中发现中度相关性。在基线和随访1之间,腰大肌的磁共振衍生脂肪分数显著增加(P = 0.016),6分钟步行试验(P = 0.006)和4级楼梯攀爬试验(P = 0.034)以及血浆肌酸激酶(P = 0.016)的表现也显著下降。在随访1和随访2之间,临床或磁共振衍生参数未发现统计学上的显著差异。
使用半自动方法对脂肪性肌肉变性进行定量可以比半定量Mercuri评分更详细地概述疾病进展。磁共振衍生数据与临床症状和患者运动能力相关。在最初恶化后,腰大肌的脂肪分数和6分钟步行试验的表现在酶替代治疗的长期随访中保持稳定。